Industries > Pharma > Biopharmaceuticals Contract Manufacturing Market Report 2020-2030

Biopharmaceuticals Contract Manufacturing Market Report 2020-2030

Forecasts by Service (Process Development (Downstream, Upstream), Fill & Finish Operations, Analytical & Quality Control Studies, Packaging), by Product (Biologics (Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Insulin), Biosimilars) Plus Analysis of Leading Companies

PUBLISHED: 04 March 2020
PAGES: 179
PRODUCT CODE: PHA0629
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1

covid-19

Market Dynamics
• Continuing expansion of biopharmaceutical manufacturing capacity by CDMOs/CMOs
• Increasing outsourcing of biopharmaceuticals-related manufacturing activities
• Increasing demand for fill-finish services in biopharmaceutical contract manufacturing market
• Increasing productivity and efficiency of biopharmaceuticals manufacturing processes
• Uptake of single-use production systems by the biopharmaceutical manufacturing industry
• Asia emerging as hot destination for biopharmaceutical manufacturing
• Increasing confidence of pharmaceutical industry in CDMOs capabilities
• High level of outsourcing of manufacturing newly approved drugs by smaller biotech companies is fueling the growth of biopharma-specific CMOs/CDMOs
• Higher acceptance and success of biopharmaceutical products in the market provides tremendous opportunities to biopharmaceuticals contract manufacturers
• Increasing shortage of skilled workforce in the biopharmaceutical industry
• Expensive manufacturing equipment requirements and complex processes raise barriers to entry, which is limiting market growth
• Complicated and stringent regulatory requirements hinder market growth

Market Segmentation 2020-2030
Biopharmaceuticals Contract Manufacturing Market is segmented on the Service, Product, and Regional basis.

Service

• Process Development
– Downstream
– Upstream

• Fill & Finish Operations
• Analytical & Quality Control Studies
• Packaging

Product

• Biologics
– Monoclonal Antibodies (MAbs)
– Recombinant Proteins
– Vaccines
– Insulin

• Biosimilars

Regional Breakdown
Focused regional forecasts and analysis explore the future opportunities:

Biopharmaceuticals Contract Manufacturing Market Report 2020-2030

• North America
– U.S.
– Canada

• Europe
– UK
– France
– Germany
– Russia
– Rest of Europe

• Asia-Pacific
– China
– Japan
– India
– Southeast Asia
– Rest of Asia Pacific

• Latin America
– Brazil
– Argentina
– Rest of Latin America

• Middle East & Africa
– GCC
– South Africa
– Rest of Middle East

Buy our report today Biopharmaceuticals Contract Manufacturing Market: Forecasts by Service (Process Development (Downstream, Upstream), Fill & Finish Operations, Analytical & Quality Control Studies, Packaging), by Product (Biologics (Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Insulin), Biosimilars) Plus Analysis of Leading Companies. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Biopharmaceuticals Contract Manufacturing Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Biopharmaceuticals Contract Manufacturing Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

READ

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

READ

Visiongain Publishes Biological Imaging Reagents Market Report 2021-2031

Increasing prevalence of cardiovascular diseases is increasing demand of biological imaging reagents for the diagnosis and treatment of cardiovascular diseases due to this reason increasing prevalence of cardiovascular diseases is acting as a driver for biological imaging reagent market.

13 November 2020

READ

Visiongain Publishes Antihypertensive Drugs Market Report 2021-2031

Hypertensive is the most common disease around the world. However, number of people suffering from hypertensive has increased very significantly from last few years. Hypertensive can occur due to consumption of tobacco, too much salt (sodium) and little potassium in your diet, alcohol and to people being overweight or obese.

13 November 2020

READ

Categories

Category